Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protamine-based heparin neutralization in open heart surgery
IRCT20180719040524N1Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Oct 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of protamine and heparin in cardiac disease (2 arms), sponsored by Rajaie Cardiovascular Medical and Research Center. Primary endpoints: Amount of bleeding, Blood cell pack consumption and 1 more. Started Oct 2018; status: completed.
02
Drugs
protamineheparin
03
Conditions
cardiac disease
Beyond the preview
Go deeper on IRCT20180719040524N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180719040524N1.